ArticleThe National medical journal of India

Adjuvant trastuzumab emtansine in human epidermal growth factor receptor 2-positive breast cancer: Take-home points from the KATHERINE trial.

Ilavarasi Vanidassane et al.PubMed ↗Publisher ↗

No numbers read from the abstract.